{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:52:15Z","timestamp":1782913935125,"version":"3.54.5"},"reference-count":66,"publisher":"Japan Oil Chemists' Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2020]]},"DOI":"10.5650\/jos.ess20067","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T22:05:38Z","timestamp":1594245938000},"page":"913-927","source":"Crossref","is-referenced-by-count":12,"title":["Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota"],"prefix":"10.5650","volume":"69","author":[{"given":"Sahar Y.","family":"Al-Okbi","sequence":"first","affiliation":[{"name":"Nutrition and Food Sciences Department, National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy A.","family":"Amin","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology department, Faculty of Pharmacy, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal E. A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology department, Faculty of Pharmacy, Cairo University"},{"name":"Microbiology and Immunology department, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr E.","family":"Edris","sequence":"additional","affiliation":[{"name":"Aroma and Flavor Chemistry, Food Industries and Nutrition Division, National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Sharaf","sequence":"additional","affiliation":[{"name":"Dairy Sciences Department, National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda B","family":"Mabrok","sequence":"additional","affiliation":[{"name":"Nutrition and Food Sciences Department, National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Nutrition and Food Sciences Department, National Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3621","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Chassaing, B.; Gewirtz, A.T. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol. 42, 49-53 (2014).","DOI":"10.1177\/0192623313508481"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chu, H.; Williams, B.; Schnabl, B. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Res. 2, 43-51 (2018).","DOI":"10.1016\/j.livres.2017.11.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kumar, D.; Tandon, R.K. Use of ursodeoxycholic acid in liver diseases. J. Gastroenterol. Hepatol. 16, 3-14 (2001).","DOI":"10.1046\/j.1440-1746.2001.02376.x"},{"key":"4","unstructured":"4) Matafome, P.; Louro, T.; Rodrigues, L.; Crisostomo, J.; Nunes, E.; Amaral, C.; Monteiro, P.; Cipriano, A.; Seica, R. Metformin and atrovastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes Metab. Res. Rev. 27, 54-62 (2011)."},{"key":"5","unstructured":"5) Reardon, J.; Hussaini, T.; Alsahafi, M.; Azalgara, V.M.; Erb, S.R.; Partovi, N.; Yoshida, E.M. Ursodeoxycholic acid in treatment of non-alcoholic fatty liver diseases: A systematic review. J. Clin. Transl. Hepatol. 4, 192-205 (2016)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Al-Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E.; Edris, A.E. Potential protective effect of Nigella sativa crude oils towards fatty liver in rats. Eur. J. Lipid Sci. Technol. 115, 774-782 (2013).","DOI":"10.1002\/ejlt.201200256"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Al-Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E.; Esmail, R.S.H. Rice bran oil and pumkin seed oil alleviate oxidative injury and fatty liver in rats fed high fructose diet. Pol. J. of Food Nutr. Sci. 64, 127-133 (2014).","DOI":"10.2478\/pjfns-2013-0002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Al-Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E.; Edris, A.E. Evaluation of the theraputic effect of Nigella sativa crude oil and its blend with omega-3 fatty acid-rich oils in a modified hepatorenal syndrome model in rats. Grasas y Aceites 66, e103 (2015).","DOI":"10.3989\/gya.0245151"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Al-Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E.; Edris, A.E.; Karem Fouda. Hepatic regeneration and reno-protection by fish oil, Nigella sativa oil, and combined fish oil\/Nigella sativa volatiles in CCl4 treated rats. J. Oleo Sci. 67, 345-353 (2018).","DOI":"10.5650\/jos.ess17204"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miguel, M.G. Antioxidant and anti-inflammatory activity of essential oils: A short review. Molecules 15, 9252-9287 (2010).","DOI":"10.3390\/molecules15129252"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ogaly, H.A.; Eltablawy, N.A.; El-Behairy, A.M.; El-Hindi, H.; Abd-Elsalam, R.M. Hepatocyte grwoth factor mediates the antifibrogenic action of Ocimum bacilicum essential oil against CCl4-induced liver fibrosis in rats. Molecules 20, 13518-13535 (2015).","DOI":"10.3390\/molecules200813518"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Samojlik, I.; Lakic, N.; Mimica-Dukic, N.; Dakovic-Svajcer, K.; Bozin, B. Antioxidant and hepatoprotective potential of essential oils of coriander (Coriandrum sativum L.) and caraway (Carum carvi L.) J. Agric. Food Chem. 58, 8848-8853 (2010).","DOI":"10.1021\/jf101645n"},{"key":"13","unstructured":"13) Issazadeh, K.; Pahlaviani, M.R.; Massiha, A.; Bidarigh, S.; Giahi, M.; Muradov, P.Z. Analysis of the phytochemical contents and anti-microbial activity of Ocimum basilicum L. Int. J. Mol. Clin. Microbiol. 2, 141-147 (2012)."},{"key":"14","unstructured":"14) Benedec, D.; Parvu, A.E.; Oniga, I.; Toiu, A.; Tiperciuc, B. Effects of Ocimum basilicum L. extract on experimental acute inflammation. Rev. Med. Chir. Soc. Med. Nat. Iasi. 111, 1065-1069 (2007)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) El-Beshbishy, H.; Bahashwan, S. Hypoglycemic effect of basil (Ocimum basilicum) aqueous extract is mediayed through inhibition of \u03b1-glucosidase and \u03b1-amylase activities: An in vitro study. Toxicol. Ind. health. 28, 42-50 (2012).","DOI":"10.1177\/0748233711403193"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Cani, P.D.; Osto, M.; Geurts, L.; Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279-288 (2012).","DOI":"10.4161\/gmic.19625"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Miura, K.; Ohnishi, H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J. Gastroenterol. 20, 7381-7391 (2014).","DOI":"10.3748\/wjg.v20.i23.7381"},{"key":"18","unstructured":"18) Porras, D.; Nistal, E.; Martinez-Florez, S.; Gonzalez-Gallego, J.; Garcia-Mediavilla, M.V.; Sanchez-Campos, S. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease. Front. Physiol. 9, 1813 (2018)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nathan, C. Epidemic inflammation; Pondering obesity. Mol. Med. 14, 485-492 (2008).","DOI":"10.2119\/2008-00038.Nathan"},{"key":"20","unstructured":"20) Hawrelak, J.A.; Cattley, T.; Myers, S.P. essential oils in the treatment of intestinal dysbiosis: A preliminary in vitro study. Altern. Med. Rev. 14, 380-384 (2009)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hamed, S.F.; Sadek, Z.; Edris, A.E. Antioxidant and antimicrobial activities of clove bud essential oil and eugenol nanoparticles in alcohol-free microemulsion. J. Oleo Sci. 61, 641-648 (2012).","DOI":"10.5650\/jos.61.641"},{"key":"22","unstructured":"22) Mondal, S.; Mirdha, B.R.; Mahapatra, S.C. The science behind sacredness of Tulsi (Ocimum sancum Linn.). Indian J. Physiol. Pharmacol. 53, 291-306 (2009)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) El-Sayed, H.S.; Chizzola, R.; Ramadan, A.A.; Edris, A.E. Chemical composition and antimicrobial activity of garlic essential oils evaluated in organic solvent, emulsifying, and self-microemulsifying water based delivery systems. Food Chem. 221, 196-204 (2017).","DOI":"10.1016\/j.foodchem.2016.10.052"},{"key":"24","unstructured":"24) Al-Okbi, S.Y.; Abdel-Razek, A.G.; Mohammed, S.E.; Ottai, M.E. Roselle seed as a potential new source of healthy edible oil. J. Biol. Sci. 17, 267-277 (2017)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kawasaki, T.; Igarashi, K.; Koeda, T.; Sugimoto, K.; Nakagawa, K.; Hayashi, S.; Yamaji, R.; Inui, H.; Fukusato, T.; Yamanouchi, T. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic Steatosis. J. Nutr. 139, 2067- 2071 (2009).","DOI":"10.3945\/jn.109.105858"},{"key":"26","unstructured":"26) Deminice, R.; de Castro, G.S.F.; Francisco, L.V.; da Silva, L.E.C.M.; Cardoso, J.F.R., Frajacomo, F.T.T.; Teodoro, B.G.; Silveira, L.R.; Jordao, A.A. Creatine supplementation prevents fatty liver in rats fed choline-deficient diet: A burden of one-carbon and fatty acid metabolism. J. Nutr. Biochem. 26, 391-397 (2015)."},{"key":"27","unstructured":"27) Watson, D. A simple method for the determination of serum cholesterol. Clinica Chim. Acta 5, 637-643 (1960)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Burstein, M.; Scholnick, H.R.; Morfin, R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11, 583-595 (1970).","DOI":"10.1016\/S0022-2275(20)42943-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Megraw, R.; Dunn, D.; Biggs, H. Manual and continuous flow colorimetry of triglycerols by a fully enzymatic method. Clin. Chem. 25, 273-284 (1979).","DOI":"10.1093\/clinchem\/25.2.273"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem.18, 499-502 (1972).","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Odeh, M.; Sabo, E.; Srugo, I.; Oliven, A. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver International 24 (2), 110-116 (2004).","DOI":"10.1111\/j.1478-3231.2004.0894.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Folch, J.; Lees, M.; Stanley, G. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226, 479-500 (1957).","DOI":"10.1016\/S0021-9258(18)64849-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Cequier-S\u00e0nchez, E.; Rodr\u00edguez, C.; Ravelo, G.; Z\u00e1rate, R. Dichloromethane as a solvent for lipid extraction and assessment of lipid classes and fatty acids from samples of different natures. J. Agric. Food Chem. 56, 4297-4303 (2008).","DOI":"10.1021\/jf073471e"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Haarmon, M.; Knol, J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving prebiotic infant formula. Appl. Environ. Microbiol. 72, 2359-2365 (2006).","DOI":"10.1128\/AEM.72.4.2359-2365.2006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Guo, X.; Xia, X.; Tang, R.; Zhou, J.; Zhao, H.; Wang, K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett. Appl. Microbiol. 47, 367-373 (2008).","DOI":"10.1111\/j.1472-765X.2008.02408.x"},{"key":"36","unstructured":"36) Bancroft, J.D.; Gamble, M. Theory and practice of histological techniques. Churchill Livingstone Elsevier, London (2008)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Buzzetti, E.; Pinzani, M.; Tsochatzis, E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). J. Metabol. 65, 1038-1048 (2016).","DOI":"10.1016\/j.metabol.2015.12.012"},{"key":"38","unstructured":"38) Al-Okbi, S.Y. Role of nutraceuticals in prevention of non-alcoholic fatty liver. in Plant- and marine-based phytochemicals for human health: Attributes, potential, and use (Goyal, M.R.; Chauhan, D.N. eds.). Apple Academic Press, Taylor and Francis, pp.131-149 (2019)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Do, M.H.; Lee, E.; Oh, M.J.; Kim, Y.; Park, H.Y. High-Glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients 10, 761 (2018).","DOI":"10.3390\/nu10060761"},{"key":"40","unstructured":"40) Lambertz, J.; Berger, T.; Mak, T.W.; van Helden, J.; Weiskirchen, R. Lipocalin-2 in fructose-induced fatty liver disease. Front. Physiol. 8, 964 (2017)."},{"key":"41","unstructured":"41) Hsieh, F.C.; Lee, C.L.; Chai, C.Y.; Chen, W.T.; Lu, Y.C.; Wu1, C.S. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr. Metab. 10, 35 (2013)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ghoshal, A.K. New insight into the biochemical pathology of liver in choline deficiency. Crit. Rev. Biochem. Mol. 30, 263-273 (1995).","DOI":"10.3109\/10409239509083487"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Vetel\u00e4inen, R.; Van Vliet, A.; Van Gulik, T.M. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J. Gastroenterol. Hepatol. 22, 1526-1533 (2007).","DOI":"10.1111\/j.1440-1746.2006.04701.x"},{"key":"44","unstructured":"44) Ye, J.Z.; Li, Y.T.; Wu, W.R.; Shi, D.; Fang, D.Q.; Yang, L.Y.; Bian, X.Y.; Wu, J.J.; Wang, Q.; Jiang, X.W.; Peng, C.G.; Ye, W.C.; Xia, P.C.; Li, L.J. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. World J. Gastroenterol. 24, 2468-2481 (2018)."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).","DOI":"10.1038\/4441022a"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Zhu, L.; Baker, R.D.; Baker, S.S. Gut microbiome and nonalcoholic fatty liver diseases. Pediatr. Res. 77, 245-251 (2015).","DOI":"10.1038\/pr.2014.157"},{"key":"47","unstructured":"47) Rabot, S.; Membrez, M.; Bruneau, A.; G\u00e9rard, P.; Harach, T.; Moser, M.; Raymond, F.; Mansourian, R.; Chou, C.J. Germ-free C57BL\/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24, 4948-4959 (2010)."},{"key":"48","unstructured":"48) Geurts, L.; Lazarevic, V.; Derrien, M.; Everard, A.; Van Roye, M.; Knauf, C.; Valet, P.; Girard, M.; Muccioli, G.G.; Fran\u00e7ois, P.; de Vos, W.M.; Schrenzel, J.; Delzenne, N.M.; Cani, P.D. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol. 2, 149 (2011)."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Polyzos, S.A.; Kountouras, J.; Zavos, C. Nonalcoholic fatty liver disease: The pathogenic roles of insulin resistance and adipocytokines. Curr. Mol. 9, 299-314 (2009).","DOI":"10.2174\/156652409787847191"},{"key":"50","unstructured":"50) Ferreira, V.S.G.; Pernambuco, R.B.; Lopes, E.P.; Morais, C.N.; Rodrigues, M.C.; Arruda, M.J.; Silva, L.M.; Vilar, L. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq. Bras. Endocrinol. Metab. 54, 362-368 (2010)."},{"key":"51","unstructured":"51) Jarrar, M.H.; Baranova, A.; Collantes, R.; Ranard, B.; Stepanova, M.; Bennett, C.; Fang, Y.; Elariny, H.; Goodman, Z.; Chandhoke, V.; Younossi, Z.M. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 27, 412-421 (2008)."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52)Lin, R.S.; Lee, F.Y.; Lee, S.D.; Tsai, Y.T.; Lin, H.C.; Lu, R.H.; Hsu, W.C.; Huang, C.C.; Wang, S.S.; Lo, K.J. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J. Hepatol. 22, 165-172 (1995).","DOI":"10.1016\/0168-8278(95)80424-2"},{"key":"53","unstructured":"53) Pinzone, M.R.; Celesia, B.M.; DiRosa, M.; Cacopardo, B.; Nunnari, G. Microbial translocation in chronic liver diseases. Int. J. Microbiol. 2012, 694629 (2012)."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Xin, J.; Zeng, D.; Wang, H.; Ni, X.; Yi, D.; Pan, K.; Jing, B. Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. Appl. Microbiol. Biotechnol. 98, 6817-6829 (2014).","DOI":"10.1007\/s00253-014-5752-1"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Borkham-Kamphorst, E.; Drews, F.; Weiskirchen, R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-in\u00a3ammatory cytokines interleukin-1B through nuclear factor-kB activation. Liver Int. 31, 656-665 (2011).","DOI":"10.1111\/j.1478-3231.2011.02495.x"},{"key":"56","unstructured":"56) Semba, T.; Nishimura, M.; Nishimura, S.; Ohara, O.; Ishige, T.; Ohno, S.; Nonaka, K.; Sogawa, K.; Satoh, M.; Sawai, S.; Matsushita, K.; Imazeki, F.; Yokosuka, O.; Nomura, F. The FLS (Fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. BMC Gastroenterol. 13, 120 (2013)."},{"key":"57","unstructured":"57) Asimakopoulou, A.; Weiskirchen, S.; Weiskirchen, R. Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. Front. Physiol. 7, 430 (2016)."},{"key":"58","unstructured":"60) Toyonaga, T.; Matsuura, M.; Mori, K.; Honzawa, Y.; Minami, N.; Yamada, S.; Kobayashi, T.; Hibi1, T.; Nakase, H. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci. Rep. 6, 35014 (2016)."},{"key":"59","unstructured":"61) Moschen, A.R.; Adolph, T.E.; Gerner, R.R.; Wieser, V.; Tilg, H. Lipocalin-2: A master mediator of intestinal and metabolic inflammation. Trends Endocrinol. Metab. 28, 388-397 (2017)."},{"key":"60","doi-asserted-by":"crossref","unstructured":"62) Nagababu, E.; Rifkind, M.; Boindala, S.; Nakka, L. Assessment of antioxidant activity of eugenol in vitro and in vivo. Methods Mol. Biol.610, 165-180 (2010).","DOI":"10.1007\/978-1-60327-029-8_10"},{"key":"61","unstructured":"63) Al-Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E.; Edris, A.E. Protective effect of clove oil and eugenol microemulsions on fatty liver and dyslipidemia as components of metabolic syndrome. J. Med. Food 17, 764-771 (2014)."},{"key":"62","doi-asserted-by":"crossref","unstructured":"64) Pandey, A.K.; Singh, P.; Tripathi, N.N. Chemistry and bioactivities of essential oils of some Ocimum species: An overview. Asian Pac. J. Trop. Biomed. 4, 682-694 (2014).","DOI":"10.12980\/APJTB.4.2014C77"},{"key":"63","unstructured":"65) Pereira, I.; Severino, P.; Santos, A.C.; Silva, A.M.; Souto, E.B. Linalool bioactive properties and potential applicability in drug delivery systems. Colloids Surf. B. 171, 566-578 (2018)."},{"key":"64","doi-asserted-by":"crossref","unstructured":"66) Wang, L.; Zhang, Y.; Fan, G.; Ren, J.N.; Zhang, L.L.; Pan, S.Y. Effects of orange essential oil on intestinal microflora in mice. J. Sci. Food Agric. 99, 4019-4028 (2019).","DOI":"10.1002\/jsfa.9629"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67) Seol, G.H.; Kim, K.Y. Eucalyptol and its role in chronic diseases. Adv. Exp. Med. Biol. 929, 389-398 (2016).","DOI":"10.1007\/978-3-319-41342-6_18"},{"key":"66","doi-asserted-by":"crossref","unstructured":"68) Cable, E.E.; Finn, P.D.; Stebbins, J.W.; Hou, J.; Ito, B.R.; van Poelje, P.D.; Linemeyer, D.L.; Erion, M.D. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 9, 407-4017 (2009).","DOI":"10.1002\/hep.22572"}],"container-title":["Journal of Oleo Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/69\/8\/69_ess20067\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T22:41:04Z","timestamp":1616539264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/69\/8\/69_ess20067\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.ess20067","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"value":"1345-8957","type":"print"},{"value":"1347-3352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}